Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water
ClinicalTrials.gov study NCT01110850. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
ClinicalTrials.gov study NCT04887259. IPD Sharing: NO. Countries: 4. Publications: 0.
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
ClinicalTrials.gov study NCT07271667. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL
ClinicalTrials.gov study NCT04155710. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL
ClinicalTrials.gov study NCT01585688. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01675102. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL
ClinicalTrials.gov study NCT01612988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
ClinicalTrials.gov study NCT04219163. IPD Sharing: NO. Countries: 1. Publications: 0.
Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients
ClinicalTrials.gov study NCT01862445. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers
ClinicalTrials.gov study NCT02991638. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Venetoclax, Rituximab and Ibrutinib in TN Patients With CLL Undetectable Minimal Residual Disease (uMRD) in Treatment-naïve Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04758975. IPD Sharing: NO. Countries: 1. Publications: 0.
Biological and Clinical Efficacy of Shingrix in Patients With CLL
ClinicalTrials.gov study NCT06364033. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib and Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia (CLL) With Response-based Obinutuzumab
ClinicalTrials.gov study NCT05650723. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
ClinicalTrials.gov study NCT06958705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01976520. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Dasatinib Combination for Chronic Lymphocytic Leukemia(CLL) With Refractory Disease
ClinicalTrials.gov study NCT01051115. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhib
ClinicalTrials.gov study NCT05555979. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL
ClinicalTrials.gov study NCT02656147. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)
ClinicalTrials.gov study NCT02273856. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
ClinicalTrials.gov study NCT03524235. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.